Tracey Lodie

Tracey Lodie is a seasoned professional in the biopharmaceutical sector, currently serving as the Chief Development Officer at GRO Biosciences and formerly as Chief Scientific Officer at Quell Therapeutics. With a distinguished career, Tracey held the position of CSO at Gamida Cell Ltd. and Senior Vice President of Translational Immunology at BlueRock Therapeutics, as well as Vice President of Immunology at Syros Pharmaceuticals. Academic credentials include a Postdoctoral Fellowship in Hematology Oncology from Harvard Medical School Beth Israel Hospital and a Ph.D. in Immunology/Pathology from Boston University School of Medicine.